March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
Warning letters raise patient safety concerns for Fentora
October 22nd 2007In response to a number of deaths and serious adverse events reported by patients taking Fentora, warning letters were sent to health care professionals. According to Cephalon, Inc., the deaths primarily occurred as a result of improper patient selection, improper dosing, and/or improper product substitution.